Volume 7, Issue 1 (2022)
SJMR 2022, 7(1): 29-39 |
Back to browse issues page
Research code: 0
Ethics code: 0
Clinical trials code: 0
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Suri F, Alinia C, Taghizadeh S, Merajipour T, Mohammadimadi S F. Clinical and economic analysis of the policy to prevent the birth of Down syndrome fetuses and evaluation of clinical ophthalmic manifestations in affected individuals. SJMR 2022; 7 (1) : 4
URL: http://saremjrm.com/article-1-257-en.html
URL: http://saremjrm.com/article-1-257-en.html
Fatemeh Suri1 
, Cyrus Alinia * 2, Sara Taghizadeh3 , Tahereh Merajipour4 , Seyed Farzad Mohammadimadi5
, Cyrus Alinia * 2, Sara Taghizadeh3 , Tahereh Merajipour4 , Seyed Farzad Mohammadimadi5
1- Assistant Professor, Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran & Secretary of Inherited Blinding Diseases Working Group, Department of Eye Health and Prevention of Blindness, Ministry of Health, Treatment and Medical Education, Tehran, Iran
2- Assistant Professor of Health Economics, Department of Health Management and Economics, School of Public Health, Urmia University of Medical Sciences, Urmia, Iran & Associate Researcher of Community Ophthalmology Research Center, Farabi Hospital, Tehran, Iran.
3- Postdoctoral Researcher, Translational Ophthalmology Research Center, Farabi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
4- Expert of Eye Health and Prevention of Blindness, Ministry of Health, Treatment and Medical Education, Tehran, Iran.
5- Associate Researcher of Community Ophthalmology Research Center, Farabi Hospital, Tehran, Iran & Professor of Cornea & External Eye Diseases, Knowledge Management Unit, Translational Ophthalmology Research Center, Farabi Hospital, Tehran University of Medical Sciences.
2- Assistant Professor of Health Economics, Department of Health Management and Economics, School of Public Health, Urmia University of Medical Sciences, Urmia, Iran & Associate Researcher of Community Ophthalmology Research Center, Farabi Hospital, Tehran, Iran.
3- Postdoctoral Researcher, Translational Ophthalmology Research Center, Farabi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
4- Expert of Eye Health and Prevention of Blindness, Ministry of Health, Treatment and Medical Education, Tehran, Iran.
5- Associate Researcher of Community Ophthalmology Research Center, Farabi Hospital, Tehran, Iran & Professor of Cornea & External Eye Diseases, Knowledge Management Unit, Translational Ophthalmology Research Center, Farabi Hospital, Tehran University of Medical Sciences.
Abstract: (1616 Views)
Introduction: Down syndrome, or trisomy 21, is a genetic disorder that without preventive intervention, about 1,000 cases of Down syndrome are expected annually among live births in Iran. More than eighty clinical features have been described in people with Down syndrome. Eye diseases occur in 60% of Down syndrome patients. These problems negatively affect the quality of life and cause complexities and issues in educational and therapeutic systems.
Material and methods: In this study, different aspects of Down syndrome with emphasis on ocular complications from 1993 to 2022, and calculating the economic burden of down syndrome by using the cost method of the disease have been performed.
Results & Discussion: Based on the expenses of the year 1399, each person with Down syndrome, on average, imposes more than 368 million Tomans annually on society during its lifetime. Also, if preventive policies are implemented with a 90% success rate and >1000 Down's syndrome births annual rate, about 381.6 billion Tomans can be saved annually. Hence, the Department of Eye Health and Prevention of Blindness, Ministry of Health and Medical Education of Iran strongly recommend taking conventional diagnostic-medical action to prevent the birth of a child with Down syndrome.
Material and methods: In this study, different aspects of Down syndrome with emphasis on ocular complications from 1993 to 2022, and calculating the economic burden of down syndrome by using the cost method of the disease have been performed.
Results & Discussion: Based on the expenses of the year 1399, each person with Down syndrome, on average, imposes more than 368 million Tomans annually on society during its lifetime. Also, if preventive policies are implemented with a 90% success rate and >1000 Down's syndrome births annual rate, about 381.6 billion Tomans can be saved annually. Hence, the Department of Eye Health and Prevention of Blindness, Ministry of Health and Medical Education of Iran strongly recommend taking conventional diagnostic-medical action to prevent the birth of a child with Down syndrome.
Article number: 4
Article Type: Original Research |
Subject:
Women Diseases
Received: 2022/05/13 | Accepted: 2022/05/31 | Published: 2023/02/12
Received: 2022/05/13 | Accepted: 2022/05/31 | Published: 2023/02/12
References
1. 1. Health supervision for children with Down syndrome. American Academy of Pediatrics Committee on Genetics. Pediatrics, 1994. 93(5): p. 855-859. [DOI:10.1542/peds.93.5.855]
2. Karami Nejad R, et al., Lived Experience of Parents of Infants with Down Syndrome from Early Diagnosis and Reactions to Child Disability. TB, 2020. 19(3): p. 12-31. [DOI:10.18502/tbj.v19i3.4170]
3. Manish N, Approach to Practical Pediatrics. 2011: New Delhi: Jaypee Brothers Medical Publishing.
4. Resta RG, Changing demographics of advanced maternal age (AMA) and the impact on the predicted incidence of Down syndrome in the United States: Implications for prenatal screening and genetic counseling. Am J Med Genet A, 2005. 133A(1): p. 31-36. [DOI:10.1002/ajmg.a.30553]
5. سارا تز and فرخنده ب, آشنایی با ژنتیک و فیزیولوژی سندرم دوان و راههای تشخیص و پیشگیری از آن. Vol. 0. 1399: کتاب صارم.
6. Roodpeyma S, Behjati F, and Shiva F, Congenital Anomalies in Newborns: Review Article. Sarem Journal of Medical Research, 2021. 6(2): p. 125-133. [DOI:10.52547/sjrm.6.2.125]
7. Bahiraei S, Daneshmandi H, and Amiri R, Physical Fitness and Health-Related Physical Activity Programs in People With Down Syndrome: A Systematic Review. J Sport Biomech, 2020. 5(4): p. 200-215. [DOI:10.32598/biomechanics.5.4.1]
8. Stefanidis K, et al., Causes of infertility in men with Down syndrome. Andrologia, 2011. 43(5): p. 353-357. [DOI:10.1111/j.1439-0272.2010.01043.x]
9. Berk AT, et al., Ocular findings in 55 patients with Down's syndrome. Ophthalmic genetics, 1996. 17(1): p. 15-19. [DOI:10.3109/13816819609057864]
10. Jazayeri O and Gorjizadeh N, A male Down syndrome with two normal boys: Cytogenetic, paternity and andrological investigations. Andrologia, 2020. 52(3): p. e13521. [DOI:10.1111/and.13521]
11. Berk AT, et al., Ocular findings in 55 patients with Down's syndrome. Ophthalmic Genet, 1996. 17(1): p. 9-15. [DOI:10.3109/13816819609057864]
12. Evenhuis HM, et al., Prevalence of visual and hearing impairment in a Dutch institutionalized population with intellectual disability. J Intellect Disabil Res, 2001. 45(Pt 5): p. 457-464. [DOI:10.1046/j.1365-2788.2001.00350.x]
13. Merrick J and Koslowe K, Refractive errors and visual anomalies in Down syndrome. Downs Syndr Res Pract, 2001. 6(3): p. 131-133. [DOI:10.3104/reports.105]
14. Roizen NJ and Patterson D, Down's syndrome. Lancet, 2003. 361(9365): p. 1281-1289. [DOI:10.1016/S0140-6736(03)12987-X]
15. da Cunha RP and Moreira JB, Ocular findings in Down's syndrome. Am J Ophthalmol, 1996. 122(2): p. 236-244. [DOI:10.1016/S0002-9394(14)72015-X]
16. Stephen E, et al., Surveillance of vision and ocular disorders in children with Down syndrome. Dev Med Child Neurol, 2007. 49(7): p. 513-515. [DOI:10.1111/j.1469-8749.2007.00513.x]
17. Watt T, Robertson K, and Jacobs RJ, Refractive error, binocular vision and accommodation of children with Down syndrome. Clin Exp Optom, 2015. 98(1): p. 3-11. [DOI:10.1111/cxo.12232]
18. Doyle L, Saunders KJ, and Little JA, Determining the relative contribution of retinal disparity and blur cues to ocular accommodation in Down syndrome. Sci Rep, 2017. 7: p. 39860. [DOI:10.1038/srep39860]
19. Paudel N, et al., Visual defects in Nepalese children with Down syndrome. Clin Exp Optom, 2010. 93(2): p. 83-90. [DOI:10.1111/j.1444-0938.2010.00458.x]
20. Fong AH, et al., Prevalence of ocular abnormalities in adults with Down syndrome in Hong Kong. Br J Ophthalmol, 2013. 97(4): p. 423-428. [DOI:10.1136/bjophthalmol-2012-302327]
21. Creavin AL and Brown RD, Ophthalmic assessment of children with down syndrome: is England doing its bit? Strabismus, 2010. 18(4): p. 142-145. [DOI:10.3109/09273972.2010.529232]
22. Hunter DG, Dynamic retinoscopy: the missing data. Surv Ophthalmol, 2001. 46(3): p. 269-274. [DOI:10.1016/S0039-6257(01)00260-0]
23. Cregg M, et al., Accommodation and refractive error in children with Down syndrome: cross-sectional and longitudinal studies. Invest Ophthalmol Vis Sci, 2001. 42(1): p. 55-63.
24. Krinsky-McHale SJ, et al., Ophthalmic disorders in adults with down syndrome. Curr Gerontol Geriatr Res, 2012. 2012: p. 974253. [DOI:10.1155/2012/974253]
25. Vincent AL, et al., Computerized corneal topography in a paediatric population with Down syndrome. Clin Exp Ophthalmol, 2005. 33(1): p. 47-52. [DOI:10.1111/j.1442-9071.2005.00941.x]
26. McMonnies CW, Mechanisms of rubbing-related corneal trauma in keratoconus. Cornea, 2009. 28(6): p. 607-615. [DOI:10.1097/ICO.0b013e318198384f]
27. Udar N, et al., SOD1 haplotypes in familial keratoconus. Cornea, 2009. 28(8): p. 902-907. [DOI:10.1097/ICO.0b013e3181983a0c]
28. Udar N, et al., SOD1: a candidate gene for keratoconus. Invest Ophthalmol Vis Sci, 2006. 47(8): p. 3345-3351. [DOI:10.1167/iovs.05-1500]
29. Nejabat M, et al., VSX1 and SOD1 Mutation Screening in Patients with Keratoconus in the South of Iran. J Ophthalmic Vis Res, 2017. 12(2): p. 135-140.
30. Al-Muammar AM, et al., Analysis of the SOD1 Gene in Keratoconus Patients from Saudi Arabia. Ophthalmic Genet, 2015. 36(4): p. 373-375. [DOI:10.3109/13816810.2014.889173]
31. Stabuc-Silih M, et al., Absence of pathogenic mutations in VSX1 and SOD1 genes in patients with keratoconus. Cornea, 2010. 29(2): p. 172-176. [DOI:10.1097/ICO.0b013e3181aebf7a]
32. Gardiner C, Lanigan B, and O'Keefe M, Postcataract surgery outcome in a series of infants and children with Down syndrome. Br J Ophthalmol, 2008. 92(8): p. 1112-1116. [DOI:10.1136/bjo.2007.134619]
33. Saifee M, Kong L, and Yen KG, Outcomes of Cataract Surgery in Children with Down Syndrome. J Ophthalmic Vis Res, 2017. 12(2): p. 243-244.
34. Li EY, et al., Cataract surgery outcomes in adult patients with Down's syndrome. Br J Ophthalmol, 2014. 98(9): p. 1273-1276. [DOI:10.1136/bjophthalmol-2013-304825]
35. Kim JH, et al., Characteristic ocular findings in Asian children with Down syndrome. Eye (Lond), 2002. 16(6): p. 710-714. [DOI:10.1038/sj.eye.6700208]
36. Arumugam A, et al., Down syndrome-A narrative review with a focus on anatomical features. Clin Anat, 2016. 29(5): p. 568-577. [DOI:10.1002/ca.22672]
37. John FM, et al., Spatial vision deficits in infants and children with Down syndrome. Invest Ophthalmol Vis Sci, 2004. 45(5): p. 1566-1572. [DOI:10.1167/iovs.03-0951]
38. Ljubic A, et al., Systemic and Ophthalmic Manifestations in Different Types of Refractive Errors in Patients with Down Syndrome. Medicina, 2022. 58(8): p. 995. [DOI:10.3390/medicina58080995]
39. Haugen OH, Hovding G, and Lundstrom I, Refractive development in children with Down's syndrome: a population based, longitudinal study. Br J Ophthalmol, 2001. 85(6): p. 714-719. [DOI:10.1136/bjo.85.6.714]
40. Berk AT, et al., Ocular findings in 55 patients with Down's syndrome. Ophthalmic Genet, 1996. 17(1): p. 15-19. [DOI:10.3109/13816819609057864]
41. Coats DK, et al., Nasolacrimal outflow drainage anomalies in Down's syndrome. Ophthalmology, 2003. 110(7): p. 1437-1441. [DOI:10.1016/S0161-6420(03)00410-X]
42. Lueder GT, Treatment of nasolacrimal duct obstruction in children with trisomy 21. J AAPOS, 2000. 4(4): p. 230-232. [DOI:10.1067/mpa.2000.105272]
43. Lueder GT, Treatment of nasolacrimal duct obstruction in children with trisomy 21. Journal of American Association for Pediatric Ophthalmology and Strabismus, 2000. 4(4): p. 230-232. [DOI:10.1067/mpa.2000.105272]
44. O'Leary L, et al., Early death and causes of death of people with Down syndrome: a systematic review. Journal of Applied Research in Intellectual Disabilities, 2018. 31(5): p. 687-708. [DOI:10.1111/jar.12446]
45. O'Leary L, Cooper SA, and Hughes‐McCormack L, Early death and causes of death of people with intellectual disabilities: a systematic review. Journal of Applied Research in Intellectual Disabilities, 2018. 31(3): p. 325-342. [DOI:10.1111/jar.12417]
46. Baker-Ericzén MJ, Brookman-Frazee L, and Stahmer A, Stress levels and adaptability in parents of toddlers with and without autism spectrum disorders. Research and practice for persons with severe disabilities, 2005. 30(4): p. 194-204. [DOI:10.2511/rpsd.30.4.194]
47. Tomanik S, Harris GE, and Hawkins J, The relationship between behaviours exhibited by children with autism and maternal stress. Journal of Intellectual and Developmental Disability, 2004. 29(1): p. 16-26. [DOI:10.1080/13668250410001662892]
48. Olsson MB and Hwang C, Depression in mothers and fathers of children with intellectual disability. Journal of intellectual disability research, 2001. 45(6): p. 535-543. [DOI:10.1046/j.1365-2788.2001.00372.x]
49. Dyson LL, Response to the presence of a child with disabilities: parental stress and family functioning over time. American journal on mental retardation, 1993.
50. Karami Nejad R, et al., Lived Experience of Parents of Infants with Down Syndrome from Early Diagnosis and Reactions to Child Disability. Tolooebehdasht, 2020. 19(3): p. 12-31. [DOI:10.18502/tbj.v19i3.4170]
51. Rangaswamy K and Bhavani K, Impact of disability on the family and needs of families of disabled children. J. Commu. Guid. Res, 2008. 25(1): p. 121-130.
52. Zeitlin S, Williamson GG, and Rosenblatt WP, The coping with stress model: A counseling approach for families with a handicapped child. Journal of Counseling & Development, 1987. 65(8): p. 443-446. [DOI:10.1002/j.1556-6676.1987.tb00752.x]
53. Benedek RS and Benedek EP, Children of divorce: Can we meet their needs? Journal of Social Issues, 1979. 35(4): p. 155-169. [DOI:10.1111/j.1540-4560.1979.tb00819.x]
54. Stone MB, et al., Improving quality of life of children with oral clefts: perspectives of parents. Journal of Craniofacial Surgery, 2010. 21(5): p. 1358-1364. [DOI:10.1097/SCS.0b013e3181ec6872]
55. Behjati F, et al., Prenatal karyotype analysis of 8245 amniotic fluid samples of Iranian women and report of their chromosomal abnormalities: A 15-year single-center study. Sarem Journal of Medical Research, 2021. 6(4): p. 199-206. [DOI:10.52547/sjrm.6.4.1]
56. Dodd K, et al., Consensus statement of the international summit on intellectual disability and dementia related to post-diagnostic support. Aging & mental health, 2018. 22(11): p. 1406-1415. [DOI:10.1080/13607863.2017.1373065]
57. Skotko B and Bedia RC, Postnatal support for mothers of children with Down syndrome. Mental retardation, 2005. 43(3): p. 196-212. [DOI:10.1352/0047-6765(2005)43[196:PSFMOC]2.0.CO;2]
58. Capone GT, et al., Co‐occurring medical conditions in adults with Down syndrome: A systematic review toward the development of health care guidelines. American Journal of Medical Genetics Part A, 2018. 176(1): p. 116-133. [DOI:10.1002/ajmg.a.38512]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
